We are live on ! Find out more
RPC

Rossmore Private Capital Portfolio holdings

AUM $1.24B
1-Year Est. Return 28.92%
This Fund
S&P 500
This Quarter Est. Return
+19.27%
1 Year Est. Return
+28.92%
3 Year Est. Return
+75.43%
5 Year Est. Return
+104.51%
10 Year Est. Return
AUM
$362M
AUM Growth
+$72.8M
Cap. Flow
+$22.2M
Cap. Flow %
6.14%
Top 10 Hldgs %
40.02%
Holding
178
New
30
Increased
93
Reduced
18
Closed
9

Top Buys

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$2.25M
2
AMZN icon
Amazon
AMZN
+$1.96M
3
MSFT icon
Microsoft
MSFT
+$1.89M
4
ADBE icon
Adobe
ADBE
+$1.01M
5
VCSH icon
Vanguard Short-Term Corporate Bond ETF
VCSH
+$999K

Sector Composition

Rank Sector Weight
1 Technology 15.36%
2 Energy 14.61%
3 Healthcare 12.8%
4 Financials 8.97%
5 Consumer Discretionary 7.72%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
IYR icon
151
iShares US Real Estate ETF
IYR
$4.67B
$245K 0.07%
3,105
DD icon
152
DuPont de Nemours
DD
$19.1B
$242K 0.07%
+3,633
New +$212K
VYM icon
153
Vanguard High Dividend Yield ETF
VYM
$81.4B
$242K 0.07%
+3,075
New +$239K
CNC icon
154
Centene
CNC
$31.5B
$241K 0.07%
+3,800
New +$247K
ZBH icon
155
Zimmer Biomet
ZBH
$18.8B
$239K 0.07%
+2,060
New +$237K
MS icon
156
Morgan Stanley
MS
$332B
$233K 0.06%
+4,815
New +$202K
SCHE icon
157
Schwab Emerging Markets Equity ETF
SCHE
$12.6B
$231K 0.06%
+9,502
New +$216K
ACWI icon
158
iShares MSCI ACWI ETF
ACWI
$32.8B
$230K 0.06%
+3,125
New +$218K
IBB icon
159
iShares Biotechnology ETF
IBB
$9.18B
$229K 0.06%
+1,674
New +$213K
RDS.A
160
DELISTED
Royal Dutch Shell PLC ADS Class A
RDS.A
$224K 0.06%
6,840
-200
-3% -$6.86K
NOC icon
161
Northrop Grumman
NOC
$77.9B
$217K 0.06%
706
-19
-3% -$6.23K
SJM icon
162
J.M. Smucker
SJM
$12.6B
$209K 0.06%
1,978
BSX icon
163
Boston Scientific
BSX
$72B
$204K 0.06%
+5,815
New +$209K
RDS.B
164
DELISTED
Royal Dutch Shell PLC ADS Class B
RDS.B
$203K 0.06%
+6,651
New +$217K
ITW icon
165
Illinois Tool Works
ITW
$83B
$201K 0.06%
+1,150
New +$188K
GE icon
166
GE Aerospace
GE
$383B
$120K 0.03%
3,539
ORMP icon
167
Oramed Pharmaceuticals
ORMP
$180M
$53K 0.01%
15,061
BMY.RT
168
DELISTED
Bristol-Myers Squibb Company Contingent Value Rights
BMY.RT
$49K 0.01%
13,652
+2,183
+19% +$7.88K
GSAT icon
169
Globalstar
GSAT
$10.8B
$12K ﹤0.01%
2,460
BABA icon
170
Alibaba
BABA
$305B
-1,134
Closed -$221K
BIL icon
171
State Street SPDR Bloomberg 1-3 Month T-Bill ETF
BIL
$46.9B
-34,983
Closed -$3.21M
EW icon
172
Edwards Lifesciences
EW
$51.1B
-17,082
Closed -$1.07M
QQQ icon
173
Invesco QQQ Trust
QQQ
$469B
-1,204
Closed -$223K
RTX icon
174
RTX Corp
RTX
$292B
-51,204
Closed -$3.04M
TGT icon
175
Target
TGT
$67.8B
-40,297
Closed -$3.75M

Similar funds

Rossmore Private Capital's Q2 2020 Portfolio in Review

As of Q2 2020, Rossmore Private Capital held 178 positions worth $362M, up 25% from $289M the previous quarter. Its ten largest holdings account for 40% of the portfolio.

Rossmore Private Capital deployed $22.2M of net new capital in Q2 2020, opening 30 new positions and adding to 93 existing holdings. Its largest new stake was SPDR Gold Trust: 5,794 shares worth $970K.

By sector, the portfolio is most concentrated in Technology at 15% of assets, up from 13% a quarter earlier, followed by Energy and Healthcare.

On the sell side, the largest reduction was iShares Core S&P Small-Cap ETF, an estimated $1.04M trimmed.

  • Rossmore Private Capital's largest Q2 2020 buy was SPDR Gold Trust: 5,794 shares worth $970K.
  • Rossmore Private Capital added most to Apple in Q2 2020, an estimated $2.25M increase.
  • Rossmore Private Capital's biggest Q2 2020 reduction was iShares Core S&P Small-Cap ETF, cutting an estimated $1.04M.
  • Rossmore Private Capital fully exited Target in Q2 2020, selling an estimated $3.75M.
  • Rossmore Private Capital's ten largest holdings make up 40% of its $362M portfolio in Q2 2020.
  • Rossmore Private Capital opened 30 new positions and closed 9 in Q2 2020.
  • Rossmore Private Capital's portfolio value rose 25% quarter-over-quarter to $362M.

Based on Rossmore Private Capital's 13F filing for Q2 2020, filed 5 Aug 2020.